Skip to main content
Top
Published in: Endocrine 3/2015

01-08-2015 | Meta-Analysis

Association between rs7903146 and rs12255372 polymorphisms of transcription factor 7-like 2 gene and polycystic ovary syndrome: a systematic review and meta-analysis

Authors: Ramon Bossardi Ramos, Vitor Costa Fabris, Letícia de Almeida Brondani, Poli Mara Spritzer

Published in: Endocrine | Issue 3/2015

Login to get access

Abstract

The present systematic review and meta-analysis of case–control studies examines the associations between rs7903146 and rs12255372 polymorphisms of the TCF7L2 gene and PCOS. A search of the literature published until August 2014 was carried out in PubMed, Cochrane Central Register of Controlled Trials, EMBASE, and LILACS. There were no other limits except for the end date. We included observational studies with women of any age diagnosed with PCOS and healthy controls that analyzed polymorphisms rs7903146 and rs12255372. We included case–control or cross-sectional studies analyzing polymorphism rs7903146 or rs12255372 in women with PCOS and healthy controls. Eighteen studies were identified after the primary literature search and seven articles were included in the meta-analysis. All employed Rotterdam criteria for the diagnosis of PCOS. The genotypic distributions in the control groups were in agreement with Hardy–Weinberg equilibrium in all studies. The pooled population included Asian descendents (Chinese, Korean), Caucasians from southern Brazil, Tunisian, and European populations (British/Irish, Northern Finns, Greeks, Czechs), including 1,892 women with PCOS and 2,695 controls. There were no significant associations between PCOS and TCF7L2 rs7903146 or rs12255372 polymorphisms, irrespective of whether allele contrast, additive, dominant, or recessive models of inheritance were used. Furthermore, no significant associations were found after stratification for ethnicity (Asian or non-Asian). There was no significant heterogeneity between studies and no publication bias. The present results suggest that rs7903146 T allele or rs12255372 is not associated with risk for PCOS in non-Asian or Asian women. This systematic review and meta-analysis are registered in PROSPERO under number CRD42013005930.
Appendix
Available only for authorised users
Literature
1.
go back to reference R. Azziz, K.S. Woods, R. Reyna, T.J. Key, E.S. Knochenhauer, B.O. Yildiz, The prevalence and features of the polycystic ovary syndrome in an unselected population. J. Clin. Endocrinol. Metab. 89, 2745–2749 (2004)PubMedCrossRef R. Azziz, K.S. Woods, R. Reyna, T.J. Key, E.S. Knochenhauer, B.O. Yildiz, The prevalence and features of the polycystic ovary syndrome in an unselected population. J. Clin. Endocrinol. Metab. 89, 2745–2749 (2004)PubMedCrossRef
2.
go back to reference W.A. March, V.M. Moore, K.J. Willson, D.I. Phillips, R.J. Norman, M.J. Davies, The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum. Reprod. 25, 544–551 (2010)PubMedCrossRef W.A. March, V.M. Moore, K.J. Willson, D.I. Phillips, R.J. Norman, M.J. Davies, The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum. Reprod. 25, 544–551 (2010)PubMedCrossRef
3.
go back to reference R. Azziz, E. Carmina, D. Dewailly, E. Diamanti-Kandarakis, H.F. Escobar-Morreale, W. Futterweit, O.E. Janssen, R.S. Legro, R.J. Norman, A.E. Taylor, S.F. Witchel, The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril. 91, 456–488 (2009)PubMedCrossRef R. Azziz, E. Carmina, D. Dewailly, E. Diamanti-Kandarakis, H.F. Escobar-Morreale, W. Futterweit, O.E. Janssen, R.S. Legro, R.J. Norman, A.E. Taylor, S.F. Witchel, The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril. 91, 456–488 (2009)PubMedCrossRef
4.
go back to reference K. Berneis, M. Rizzo, M. Hersberger, G.B. Rini, G. Di Fede, I. Pepe, G.A. Spinas, E. Carmina, Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome. Int. J. Clin. Pract. 63, 56–62 (2009)PubMedCrossRef K. Berneis, M. Rizzo, M. Hersberger, G.B. Rini, G. Di Fede, I. Pepe, G.A. Spinas, E. Carmina, Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome. Int. J. Clin. Pract. 63, 56–62 (2009)PubMedCrossRef
5.
go back to reference E. Diamanti-Kandarakis, P.M. Spritzer, T. Sir-Petermann, A.B. Motta, Insulin resistance and polycystic ovary syndrome through life. Curr. Pharm. Des. 18, 5569–5576 (2012)PubMedCrossRef E. Diamanti-Kandarakis, P.M. Spritzer, T. Sir-Petermann, A.B. Motta, Insulin resistance and polycystic ovary syndrome through life. Curr. Pharm. Des. 18, 5569–5576 (2012)PubMedCrossRef
7.
go back to reference R.J. Norman, D. Dewailly, R.S. Legro, T.E. Hickey, Polycystic ovary syndrome. Lancet 370, 685–697 (2007)PubMedCrossRef R.J. Norman, D. Dewailly, R.S. Legro, T.E. Hickey, Polycystic ovary syndrome. Lancet 370, 685–697 (2007)PubMedCrossRef
8.
go back to reference R.A. Wild, E. Carmina, E. Diamanti-Kandarakis, A. Dokras, H.F. Escobar-Morreale, W. Futterweit, R. Lobo, R.J. Norman, E. Talbott, D.A. Dumesic, Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J. Clin. Endocrinol. Metab. 95, 2038–2049 (2010)PubMedCrossRef R.A. Wild, E. Carmina, E. Diamanti-Kandarakis, A. Dokras, H.F. Escobar-Morreale, W. Futterweit, R. Lobo, R.J. Norman, E. Talbott, D.A. Dumesic, Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J. Clin. Endocrinol. Metab. 95, 2038–2049 (2010)PubMedCrossRef
9.
go back to reference R.S. Legro, A.R. Kunselman, W.C. Dodson, A. Dunaif, Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J. Clin. Endocrinol. Metab. 84, 165–169 (1999)PubMed R.S. Legro, A.R. Kunselman, W.C. Dodson, A. Dunaif, Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J. Clin. Endocrinol. Metab. 84, 165–169 (1999)PubMed
10.
go back to reference D.A. Ehrmann, R.B. Barnes, R.L. Rosenfield, M.K. Cavaghan, J. Imperial, Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22, 141–146 (1999)PubMedCrossRef D.A. Ehrmann, R.B. Barnes, R.L. Rosenfield, M.K. Cavaghan, J. Imperial, Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22, 141–146 (1999)PubMedCrossRef
11.
go back to reference M.R. Jones, A.K. Chua, E.A. Mengesha, K.D. Taylor, Y.D. Chen, X. Li, R.M. Krauss, J.I. Rotter, R.S. Legro, R. Azziz, M.O. Goodarzi, Metabolic and cardiovascular genes in polycystic ovary syndrome: a candidate-wide association study (CWAS). Steroids 77, 317–322 (2012)PubMedCentralPubMedCrossRef M.R. Jones, A.K. Chua, E.A. Mengesha, K.D. Taylor, Y.D. Chen, X. Li, R.M. Krauss, J.I. Rotter, R.S. Legro, R. Azziz, M.O. Goodarzi, Metabolic and cardiovascular genes in polycystic ovary syndrome: a candidate-wide association study (CWAS). Steroids 77, 317–322 (2012)PubMedCentralPubMedCrossRef
12.
go back to reference A. Biyasheva, R.S. Legro, A. Dunaif, M. Urbanek, Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2. J. Clin. Endocrinol. Metab. 94, 2617–2625 (2009)PubMedCentralPubMedCrossRef A. Biyasheva, R.S. Legro, A. Dunaif, M. Urbanek, Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2. J. Clin. Endocrinol. Metab. 94, 2617–2625 (2009)PubMedCentralPubMedCrossRef
13.
go back to reference D.A. Ehrmann, X. Tang, I. Yoshiuchi, N.J. Cox, G.I. Bell, Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 87, 4297–4300 (2002)PubMedCrossRef D.A. Ehrmann, X. Tang, I. Yoshiuchi, N.J. Cox, G.I. Bell, Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 87, 4297–4300 (2002)PubMedCrossRef
14.
go back to reference S. Radavelli-Bagatini, I.O. de Oliveira, R.B. Ramos, B.R. Santos, M.S. Wagner, S.B. Lecke, D.P. Gigante, B.L. Horta, P.M. Spritzer, Haplotype TGTG from SNP 45T/G and 276G/T of the adiponectin gene contributes to risk of polycystic ovary syndrome. J. Endocrinol. Invest. 36, 497–502 (2013)PubMed S. Radavelli-Bagatini, I.O. de Oliveira, R.B. Ramos, B.R. Santos, M.S. Wagner, S.B. Lecke, D.P. Gigante, B.L. Horta, P.M. Spritzer, Haplotype TGTG from SNP 45T/G and 276G/T of the adiponectin gene contributes to risk of polycystic ovary syndrome. J. Endocrinol. Invest. 36, 497–502 (2013)PubMed
15.
go back to reference P. Wojciechowski, A. Lipowska, P. Rys, K.G. Ewens, S. Franks, S. Tan, E. Lerchbaum, J. Vcelak, R. Attaoua, M. Straczkowski, R. Azziz, T.M. Barber, A. Hinney, B. Obermayer-Pietsch, P. Lukasova, B. Bendlova, F. Grigorescu, I. Kowalska, M.O. Goodarzi, J.F. Strauss 3rd, M.I. McCarthy, M.T. Malecki, Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis. Diabetologia 55, 2636–2645 (2012)PubMedCentralPubMedCrossRef P. Wojciechowski, A. Lipowska, P. Rys, K.G. Ewens, S. Franks, S. Tan, E. Lerchbaum, J. Vcelak, R. Attaoua, M. Straczkowski, R. Azziz, T.M. Barber, A. Hinney, B. Obermayer-Pietsch, P. Lukasova, B. Bendlova, F. Grigorescu, I. Kowalska, M.O. Goodarzi, J.F. Strauss 3rd, M.I. McCarthy, M.T. Malecki, Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis. Diabetologia 55, 2636–2645 (2012)PubMedCentralPubMedCrossRef
16.
go back to reference N. Xita, I. Georgiou, A. Tsatsoulis, The genetic basis of polycystic ovary syndrome. Eur. J. Endocrinol. 147, 717–725 (2002)PubMedCrossRef N. Xita, I. Georgiou, A. Tsatsoulis, The genetic basis of polycystic ovary syndrome. Eur. J. Endocrinol. 147, 717–725 (2002)PubMedCrossRef
17.
go back to reference S.K. Yalamanchi, S. Sam, M.O. Cardenas, L.W. Holaday, M. Urbanek, A. Dunaif, Association of fibrillin-3 and transcription factor-7-like 2 gene variants with metabolic phenotypes in PCOS. Obesity 20, 1273–1278 (2012)PubMedCentralPubMedCrossRef S.K. Yalamanchi, S. Sam, M.O. Cardenas, L.W. Holaday, M. Urbanek, A. Dunaif, Association of fibrillin-3 and transcription factor-7-like 2 gene variants with metabolic phenotypes in PCOS. Obesity 20, 1273–1278 (2012)PubMedCentralPubMedCrossRef
19.
go back to reference S.F. Grant, G. Thorleifsson, I. Reynisdottir, R. Benediktsson, A. Manolescu, J. Sainz, A. Helgason, H. Stefansson, V. Emilsson, A. Helgadottir, U. Styrkarsdottir, K.P. Magnusson, G.B. Walters, E. Palsdottir, T. Jonsdottir, T. Gudmundsdottir, A. Gylfason, J. Saemundsdottir, R.L. Wilensky, M.P. Reilly, D.J. Rader, Y. Bagger, C. Christiansen, V. Gudnason, G. Sigurdsson, U. Thorsteinsdottir, J.R. Gulcher, A. Kong, K. Stefansson, Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 38, 320–323 (2006)PubMedCrossRef S.F. Grant, G. Thorleifsson, I. Reynisdottir, R. Benediktsson, A. Manolescu, J. Sainz, A. Helgason, H. Stefansson, V. Emilsson, A. Helgadottir, U. Styrkarsdottir, K.P. Magnusson, G.B. Walters, E. Palsdottir, T. Jonsdottir, T. Gudmundsdottir, A. Gylfason, J. Saemundsdottir, R.L. Wilensky, M.P. Reilly, D.J. Rader, Y. Bagger, C. Christiansen, V. Gudnason, G. Sigurdsson, U. Thorsteinsdottir, J.R. Gulcher, A. Kong, K. Stefansson, Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 38, 320–323 (2006)PubMedCrossRef
20.
go back to reference C.J. Groves, E. Zeggini, J. Minton, T.M. Frayling, M.N. Weedon, N.W. Rayner, G.A. Hitman, M. Walker, S. Wiltshire, A.T. Hattersley, M.I. McCarthy, Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes 55, 2640–2644 (2006)PubMedCrossRef C.J. Groves, E. Zeggini, J. Minton, T.M. Frayling, M.N. Weedon, N.W. Rayner, G.A. Hitman, M. Walker, S. Wiltshire, A.T. Hattersley, M.I. McCarthy, Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes 55, 2640–2644 (2006)PubMedCrossRef
22.
go back to reference J.C. Florez, K.A. Jablonski, N. Bayley, T.I. Pollin, P.I. de Bakker, A.R. Shuldiner, W.C. Knowler, D.M. Nathan, D. Altshuler, TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N. Engl. J. Med. 355, 241–250 (2006)PubMedCentralPubMedCrossRef J.C. Florez, K.A. Jablonski, N. Bayley, T.I. Pollin, P.I. de Bakker, A.R. Shuldiner, W.C. Knowler, D.M. Nathan, D. Altshuler, TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N. Engl. J. Med. 355, 241–250 (2006)PubMedCentralPubMedCrossRef
23.
go back to reference V. Lyssenko, R. Lupi, P. Marchetti, S. Del Guerra, M. Orho-Melander, P. Almgren, M. Sjogren, C. Ling, K.F. Eriksson, A.L. Lethagen, R. Mancarella, G. Berglund, T. Tuomi, P. Nilsson, S. Del Prato, L. Groop, Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J. Clin. Invest. 117, 2155–2163 (2007)PubMedCentralPubMedCrossRef V. Lyssenko, R. Lupi, P. Marchetti, S. Del Guerra, M. Orho-Melander, P. Almgren, M. Sjogren, C. Ling, K.F. Eriksson, A.L. Lethagen, R. Mancarella, G. Berglund, T. Tuomi, P. Nilsson, S. Del Prato, L. Groop, Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J. Clin. Invest. 117, 2155–2163 (2007)PubMedCentralPubMedCrossRef
24.
go back to reference R. Saxena, L. Gianniny, N.P. Burtt, V. Lyssenko, C. Giuducci, M. Sjogren, J.C. Florez, P. Almgren, B. Isomaa, M. Orho-Melander, U. Lindblad, M.J. Daly, T. Tuomi, J.N. Hirschhorn, K.G. Ardlie, L.C. Groop, D. Altshuler, Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 55, 2890–2895 (2006)PubMedCrossRef R. Saxena, L. Gianniny, N.P. Burtt, V. Lyssenko, C. Giuducci, M. Sjogren, J.C. Florez, P. Almgren, B. Isomaa, M. Orho-Melander, U. Lindblad, M.J. Daly, T. Tuomi, J.N. Hirschhorn, K.G. Ardlie, L.C. Groop, D. Altshuler, Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 55, 2890–2895 (2006)PubMedCrossRef
25.
go back to reference C.F. Deacon, Therapeutic strategies based on glucagon-like peptide 1. Diabetes 53, 2181–2189 (2004)PubMedCrossRef C.F. Deacon, Therapeutic strategies based on glucagon-like peptide 1. Diabetes 53, 2181–2189 (2004)PubMedCrossRef
26.
go back to reference F. Yi, P.L. Brubaker, T. Jin, TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J. Biol. Chem. 280, 1457–1464 (2005)PubMedCrossRef F. Yi, P.L. Brubaker, T. Jin, TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J. Biol. Chem. 280, 1457–1464 (2005)PubMedCrossRef
27.
go back to reference W.J. Shen, T.R. Li, Y.J. Hu, H.B. Liu, M. Song, Relationships between TCF7L2 genetic polymorphisms and polycystic ovary syndrome risk: a meta-analysis. Metab. Syndr. Relat. Disord. 12, 210–219 (2014)PubMedCrossRef W.J. Shen, T.R. Li, Y.J. Hu, H.B. Liu, M. Song, Relationships between TCF7L2 genetic polymorphisms and polycystic ovary syndrome risk: a meta-analysis. Metab. Syndr. Relat. Disord. 12, 210–219 (2014)PubMedCrossRef
28.
go back to reference L. Lin, J. Yang, Y. Ding, J. Wang, L. Ting, Genetic polymorphisms of TCF7L2 lack influence on risk of the polycystic ovary syndrome—a systemic analysis. Asian Pac. J. Cancer Prev. 15, 3331–3333 (2014)PubMedCrossRef L. Lin, J. Yang, Y. Ding, J. Wang, L. Ting, Genetic polymorphisms of TCF7L2 lack influence on risk of the polycystic ovary syndrome—a systemic analysis. Asian Pac. J. Cancer Prev. 15, 3331–3333 (2014)PubMedCrossRef
29.
go back to reference A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. Gotzsche, J.P. Ioannidis, M. Clarke, P.J. Devereaux, J. Kleijnen, D. Moher, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339, b2700 (2009)PubMedCentralPubMedCrossRef A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. Gotzsche, J.P. Ioannidis, M. Clarke, P.J. Devereaux, J. Kleijnen, D. Moher, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339, b2700 (2009)PubMedCentralPubMedCrossRef
30.
go back to reference D.F. Stroup, J.A. Berlin, S.C. Morton, I. Olkin, G.D. Williamson, D. Rennie, D. Moher, B.J. Becker, T.A. Sipe, S.B. Thacker, Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283, 2008–2012 (2000)PubMedCrossRef D.F. Stroup, J.A. Berlin, S.C. Morton, I. Olkin, G.D. Williamson, D. Rennie, D. Moher, B.J. Becker, T.A. Sipe, S.B. Thacker, Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283, 2008–2012 (2000)PubMedCrossRef
32.
go back to reference C. Minelli, J.R. Thompson, K.R. Abrams, A. Thakkinstian, J. Attia, The choice of a genetic model in the meta-analysis of molecular association studies. Int. J. Epidemiol. 34, 1319–1328 (2005)PubMedCrossRef C. Minelli, J.R. Thompson, K.R. Abrams, A. Thakkinstian, J. Attia, The choice of a genetic model in the meta-analysis of molecular association studies. Int. J. Epidemiol. 34, 1319–1328 (2005)PubMedCrossRef
33.
go back to reference E. Zintzaras, J. Lau, Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J. Clin. Epidemiol. 61, 634–645 (2008)PubMedCrossRef E. Zintzaras, J. Lau, Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J. Clin. Epidemiol. 61, 634–645 (2008)PubMedCrossRef
34.
go back to reference J.P. Higgins, S.G. Thompson, Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539–1558 (2002)PubMedCrossRef J.P. Higgins, S.G. Thompson, Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539–1558 (2002)PubMedCrossRef
37.
go back to reference S. Tan, A. Scherag, O.E. Janssen, S. Hahn, H. Lahner, T. Dietz, S. Scherag, H. Grallert, C.I. Vogel, R. Kimmig, T. Illig, K. Mann, J. Hebebrand, A. Hinney, Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS). BMC Med. Genet. 11, 12 (2010)PubMedCentralPubMedCrossRef S. Tan, A. Scherag, O.E. Janssen, S. Hahn, H. Lahner, T. Dietz, S. Scherag, H. Grallert, C.I. Vogel, R. Kimmig, T. Illig, K. Mann, J. Hebebrand, A. Hinney, Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS). BMC Med. Genet. 11, 12 (2010)PubMedCentralPubMedCrossRef
38.
go back to reference K.G. Ewens, M.R. Jones, W. Ankener, D.R. Stewart, M. Urbanek, A. Dunaif, R.S. Legro, A. Chua, R. Azziz, R.S. Spielman, M.O. Goodarzi, J.F. Strauss 3rd, Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome. Fertil. Steril. 95(2538–2541), e2531–e2536 (2011) K.G. Ewens, M.R. Jones, W. Ankener, D.R. Stewart, M. Urbanek, A. Dunaif, R.S. Legro, A. Chua, R. Azziz, R.S. Spielman, M.O. Goodarzi, J.F. Strauss 3rd, Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome. Fertil. Steril. 95(2538–2541), e2531–e2536 (2011)
39.
go back to reference T.M. Barber, A.J. Bennett, C.J. Groves, U. Sovio, A. Ruokonen, H. Martikainen, A. Pouta, A.L. Hartikainen, P. Elliott, J.A. Wass, M.R. Jarvelin, E. Zeggini, S. Franks, M.I. McCarthy, Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS. Diabetologia 50, 2318–2322 (2007)PubMedCrossRef T.M. Barber, A.J. Bennett, C.J. Groves, U. Sovio, A. Ruokonen, H. Martikainen, A. Pouta, A.L. Hartikainen, P. Elliott, J.A. Wass, M.R. Jarvelin, E. Zeggini, S. Franks, M.I. McCarthy, Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS. Diabetologia 50, 2318–2322 (2007)PubMedCrossRef
40.
go back to reference A. Ben-Salem, M. Ajina, M. Suissi, H.S. Daher, W.Y. Almawi, T. Mahjoub, Polymorphisms of transcription factor-7-like 2 (TCF7L2) gene in Tunisian women with polycystic ovary syndrome (PCOS). Gene 533, 554–557 (2013)PubMedCrossRef A. Ben-Salem, M. Ajina, M. Suissi, H.S. Daher, W.Y. Almawi, T. Mahjoub, Polymorphisms of transcription factor-7-like 2 (TCF7L2) gene in Tunisian women with polycystic ovary syndrome (PCOS). Gene 533, 554–557 (2013)PubMedCrossRef
41.
go back to reference P. Christopoulos, G. Mastorakos, M. Gazouli, D. Panidis, E. Deligeoroglou, I. Katsikis, K. Papadias, E. Diamandi-Kandarakis, G. Creatsas, Genetic variants in TCF7L2 and KCNJ11 genes in a Greek population with polycystic ovary syndrome. Gynecol. Endocrinol. 24, 486–490 (2008)PubMedCrossRef P. Christopoulos, G. Mastorakos, M. Gazouli, D. Panidis, E. Deligeoroglou, I. Katsikis, K. Papadias, E. Diamandi-Kandarakis, G. Creatsas, Genetic variants in TCF7L2 and KCNJ11 genes in a Greek population with polycystic ovary syndrome. Gynecol. Endocrinol. 24, 486–490 (2008)PubMedCrossRef
42.
go back to reference J.J. Kim, Y.M. Choi, Y.M. Cho, M.A. Hong, S.J. Chae, K.R. Hwang, S.S. Hwang, S.H. Yoon, S.Y. Moon, Polycystic ovary syndrome is not associated with polymorphisms of the TCF7L2, CDKAL1, HHEX, KCNJ11, FTO and SLC30A8 genes. Clin Endocrinol. 77, 439–445 (2012)CrossRef J.J. Kim, Y.M. Choi, Y.M. Cho, M.A. Hong, S.J. Chae, K.R. Hwang, S.S. Hwang, S.H. Yoon, S.Y. Moon, Polycystic ovary syndrome is not associated with polymorphisms of the TCF7L2, CDKAL1, HHEX, KCNJ11, FTO and SLC30A8 genes. Clin Endocrinol. 77, 439–445 (2012)CrossRef
43.
go back to reference R.B. Ramos, D. Wiltgen, P.M. Spritzer, Polymorphisms of TCF7L2 gene in South Brazilian women with polycystic ovary syndrome: a cross-sectional study. Eur. J. Endocrinol. 169, 569–576 (2013)PubMedCrossRef R.B. Ramos, D. Wiltgen, P.M. Spritzer, Polymorphisms of TCF7L2 gene in South Brazilian women with polycystic ovary syndrome: a cross-sectional study. Eur. J. Endocrinol. 169, 569–576 (2013)PubMedCrossRef
44.
go back to reference J. Vcelak, D. Vejrazkova, M. Vankova, P. Lukasova, O. Bradnova, T. Halkova, J. Bestak, K. Andelova, H. Kvasnickova, P. Hoskovcova, K. Vondra, J. Vrbikova, B. Bendlova, T2D risk haplotypes of the TCF7L2 gene in the Czech population sample: the association with free fatty acids composition. Physiol. Res. 61, 229–240 (2012)PubMed J. Vcelak, D. Vejrazkova, M. Vankova, P. Lukasova, O. Bradnova, T. Halkova, J. Bestak, K. Andelova, H. Kvasnickova, P. Hoskovcova, K. Vondra, J. Vrbikova, B. Bendlova, T2D risk haplotypes of the TCF7L2 gene in the Czech population sample: the association with free fatty acids composition. Physiol. Res. 61, 229–240 (2012)PubMed
45.
go back to reference P. Xu, Y. Che, Y. Cao, X. Wu, H. Sun, F. Liang, J. Sun, L. Ke, L. Yi, Y. Wang, Polymorphisms of TCF7L2 and HHEX genes in Chinese women with polycystic ovary syndrome. J. Assist. Reprod. Genet. 27, 23–28 (2010)PubMedCentralPubMedCrossRef P. Xu, Y. Che, Y. Cao, X. Wu, H. Sun, F. Liang, J. Sun, L. Ke, L. Yi, Y. Wang, Polymorphisms of TCF7L2 and HHEX genes in Chinese women with polycystic ovary syndrome. J. Assist. Reprod. Genet. 27, 23–28 (2010)PubMedCentralPubMedCrossRef
Metadata
Title
Association between rs7903146 and rs12255372 polymorphisms of transcription factor 7-like 2 gene and polycystic ovary syndrome: a systematic review and meta-analysis
Authors
Ramon Bossardi Ramos
Vitor Costa Fabris
Letícia de Almeida Brondani
Poli Mara Spritzer
Publication date
01-08-2015
Publisher
Springer US
Published in
Endocrine / Issue 3/2015
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-015-0541-x

Other articles of this Issue 3/2015

Endocrine 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.